ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics

Clinical Drug Trials

Search results for
Clinical Drug Trials

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 790

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Clinical Drug Trials

A  is a study that is purposely designed to test the points of interest and threats of a specific therapeutic treatment or intercession, such as new drug or a behaviour change. Clinical trials are one of the final stages of a long and careful research process. The process often begins in a laboratory (lab), where scientists first develop and test new ideas. If an approach seems promising, the next step may involve animal testing. This shows how the approach affects a living body and whether it's harmful. However, an approach that works well in the lab or animals doesn't always work well in people. Thus, research in humans is needed.

Journals related to Clinical drug trials
Journal of Developing DrugsDrug Designing: Journal of Clinical Trials, Contemporary Clinical Trials, International Journal of Clinical Trials, , Journal of Clinical Trials, Journal of Clinical Trials, PLOS Clinical Trials, Journal of Cancer Clinical Trials, Drug Development and Industrial Pharmacy, Journal of Clinical Medicine Research, Controlled Clinical Trials

Clinical Drug Trials

Expert PPTs

Speaker PPTs

  • Hanieh S Musavian
    Factory trials and evaluations of steam-ultrasound (SonoSteam®) decontamination of broilers
    | PDF Version
  • Sundeep Kumar Upadhyaya
    LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
    | PDF Version
  • Vicky Stewart
    Clinical Effectiveness of Physiotherapy-led Vestibular Service in tertiary hospital
    | PDF Version
  • Li Yu-Jung
    Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
    | PDF Version
  • Trent Jackman
    Exploratory comparison of credentialed clinical instructors’ and non-credentialed clinical instructors’ report of frequency and importance of professional behaviors in clinical education
    | PDF Version
  • B Saranya
    Clinical presentation of ectopic pregnancy presented as PID – A case report
    | PDF Version
  • Sribatsa Kumar Mahapatra
    Triple ABC Technique in Clinical Assessment in Breast Cancer Diagnosis
    | PDF Version
  • Daisuke Ota
    The clinical outcome of reconstruction with tissue expander for breast cancer patients with mastectomy
    | PDF Version
  • Carsten Worsoe
    The value of the “simulated study” as a tool to predict actual leachables in parenteral drug products
    | PDF Version
  • Diane Paskiet
    Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
    | PDF Version
  • Li-Chun Tsou
    Drug delivery device strategy for patient centric therapies
    | PDF Version
  • Neervalur V Raghavan
    Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
    | PDF Version
  • Panayiotis P Constantinides
    Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
    | PDF Version
  • Jan Voskuil
    How antibodies can prevent medical progress and how they can be great tools?
    | PDF Version
  • Francis Jeshira Reynoso
    The clinical phenotype of PIGN deficiency and consequences of defective GPI biogenesis
    | PDF Version
  • Eli Raveh
    From chromosomal instability to metastases- H19’s role in cancer progression and its clinical significance
    | PDF Version
  • Arshad mahmood
    TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
    | PDF Version
  • Hugo Albrecht
    Towards pharmacological validation of MNKs as anti-cancer drug targets
    | PDF Version
  • Vivek Lal
    New drug development in type-2 diabetes mellitus : current and future trends – an overview
    | PDF Version
  • Joan Smith Sonneborn
    Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
    | PDF Version
  • Sonia Escaich
    Tat Oyi-based candidate therapeutic vaccine: a successful phase 1 clinical trial in HIV-1 infected patients
    | PDF Version
  • Sergey Suchkov
    Translational tools as applicable to autoimmune disorders: antibody-proteases as a generation of highly informative and unique biomarkers to monitor subclinical and clinical stages of demyelination in multiple sclerosis (MS)
    | PDF Version
  • Barbara Klajnert-Maculewicz
    Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
    | PDF Version
  • Adel Nefzi
    “Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery”
    | PDF Version
  • Vladimir Obolensky
    Efficacy of electrical muscle stimulation in clinical practice
    | PDF Version
  • Vivien Xi WU
    Perspectives of Hospital Nurse Educators, Clinicians and Managers on Clinical Assessment for Undergraduate Nursing Students
    | PDF Version
  • Tanvir Ahmed
    Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
    | PDF Version
  • Shivanand Reddy
    Relation between low serum testosterone level and peripheral arterial disease in men and clinical evaluation of effect of testosterone administration
    | PDF Version
  • Senthilkumar Gandhidasan
    Clinical leadership – an essential requirement for successful health information system implementation
    | PDF Version
  • Placide Poba-Nzaou
    Open Source as an Alternative for Clinical Information Systems Adoption
    | PDF Version
  • James J Cimino
    Querying Four Decades of Clinical Research Data at the National Institutes of Health
    | PDF Version
  • Mukesh Kumar
    Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
    | PDF Version
  • Kirill Shlyapnikov
    Fibromyalgia and chronic fatigue syndrome (CFS): translational biomarkers as applicable to monitor and to predict clinical manifestations
    | PDF Version
  • Thomas J Franz
    Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Almas Okassov
    Chemical modification of anticancer Parasporins for decreasing of their toxicity
    | PDF Version
  • G Ambica
    Clinical management of soya bean associated alkaline indigestion in a bullock: A case presentation
    | PDF Version
  • Chokkadi Sreepathi Bhagyajyothi
    Workshop on Statistical Versus Clinical Significance
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • J.Y. Cindy Kim
    Forensic Mental Health Treatment in Juvenile Justice Secure Care Facilities For Juvenile Fire Setters and Bomb Makers Clinical and Forensic Public Safety Recommendations
    | PDF Version
  • Sevgi Gungor
    Micelles as nanosized carriers for skin delivery of drugs
    | PDF Version
  • Ru Band Lu
    Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • Vasantha Kumari Neela
    Could clinical Stenotrophomonasmaltophilia be a potential pathogen in clinical setting?
    | PDF Version
  • Almagul Kushugulova
    Research and development new symbiotic product and its clinical effect
    | PDF Version
  • Vikas Kumar
    Potential Clinical Applications of Probiotics
    | PDF Version
  • Aisa N. Muya
    Clinical and immunologic pattern of PLHIV lost from HIV care before initiated Antiretroviral treatment within an HIV Program in Tanzania
    | PDF Version
  • Sungchul Ji
    Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
    | PDF Version
  • Anita Nair
    BCS-Based Biowaivers: Which Drugs are Eligible?
    | PDF Version
  • Adriana Katz
    Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
    | PDF Version
  • Eggehard Holler
    Biodegradable nanobrushes for drug delivery
    | PDF Version
  • Tao Lu
    Using VBIM technique to identify drug resistance genes in ovarian cancer
    | PDF Version
  • Lavinia-Oltita Brătescu
    Hepcidin-25-A useful clinical guide for iron-restricted erythropoiesis detection in haemodialysis patients
    | PDF Version
  • Mohamed Khaled El Hatw
    Rapid accelerated hemodialysis in children with end-stage renal disease: A randomized clinical trial
    | PDF Version
  • Navneet Sharma
    Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
    | PDF Version
  • Viral Kansara
    Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
    | PDF Version
  • Richard A. Kenley
    Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
    | PDF Version
  • Elena Gavrilova
    Application of drugs based on release-active antibodies as immunotherapy agents
    | PDF Version
  • William Lee
    Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
    | PDF Version
  • Krasimira Pekova
    Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
    | PDF Version
  • Pablo Javier Marchena Yglesias
    ACUTE REACTIVES AND MARKERS OF INFLAMMATION IN VENOUS THROMBOEMBOLISM DISEASE: CLINICAL AND EVOLUTION OUTCOMES
    | PDF Version
  • Alexandre Caixeta Guimaraes
    The Clinical Manifestations In Children With Tonsillar Lymphoma
    | PDF Version
  • Gabriela Gheorghe
    AML with t (8;16) shows unique clinical, morphological and immunophenotypic features
    | PDF Version
  • Effie Liakopoulou
    Whole genome methodology for in silico quantification of intra tumor heterogeneity: Model for clinical applications in the treatment of patients with hematological malignancies
    | PDF Version
  • Jasmin Kaur
    Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
    | PDF Version
  • Matin Peters
    Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
    | PDF Version
  • Lynda Sharrett Field
    Preclinical studies of glucocorticoid receptor antagonists in the treatment of alcohol dependence
    | PDF Version
  • Marcelo Febo
    3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
    | PDF Version
  • Helene Corriveau
    Evaluation of risk of fall on frail elderly: The reliability and validity study of an obstacle course, the Sherbrooke Functional Evaluation of the Risk of falls in Elderly (SFERE)
    | PDF Version
  • Jim Klostergaard
    Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
    | PDF Version
  • Sree Harsha
    Optimization of particles size for lung specific drug delivery by way of microspheres
    | PDF Version
  • Mauro Comes Franchini
    Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
    | PDF Version
  • W Wagner
    Tumor regression by means of magnetic drug targeting
    | PDF Version
  • Melinda Nagy-Vincze
    Clinical advances of anti-TIF1γ autoantibody in a Hungarian myositis cohort
    | PDF Version
  • Sergio Marcucci
    Sacroiliac joint biomechanics and its potential clinical implications
    | PDF Version
  • Ray Marks
    Depressive symptoms among older adults with mild to moderate Knee osteoarthritis are highly prevalent and are predicted by disease management self-efficacy: A cross-sectional study of depressive symptom prevalence, and clinical interrelationships
    | PDF Version
  • Jung-Joon Min
    Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
    | PDF Version
  • Maria Paola COSTI
    A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
    | PDF Version
  • Vladimir Torchilin
    Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
    | PDF Version
  • Meg Mangin
    Clinical Evidence of Immune System Dysregulation Caused by Intracellular Infection
    | PDF Version
  • Baharudin Ibrahim
    Personalizing drug treatment using pharmacometabonomic approach
    | PDF Version
  • Shamim Ahmad
    Honey: Clinical applications and scope as an alternate antibacterial therapy in multi- resistant ocular bacterial infections especially involving MRSA
    | PDF Version
  • Vladimir V Tolstikov
    Clinical Metabolomics: Case study CKD. Cross-platform omics data integration in Ingenuity Systems.
    | PDF Version
  • Ruben Artero
    A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
    | PDF Version
  • Vladimir E. Bondarenko
    Mathematical model of β1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
    | PDF Version
  • Maria ISAGULIANTS
    DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
    | PDF Version
  • Roger S. Klotz
    Nutritional planning by the pharmacist for patients with chronic diseases
    | PDF Version
  • Caglar Macit
    The Impact of pharmacist-led patient education on adherence to antibiotic therapy in primary care
    | PDF Version
  • James Hendrix
    Discovery of a first-in-class topically bioavailable kit inhibitor with clinical activity using computational chemogenomics technology
    | PDF Version
  • Grace London
    Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
    | PDF Version
  • Antonio Ferrari
    Spontaneous Ventricular Arrhythmias in Early Clinical Trials A Report from a Single and Repeated Ascending Dose Study
    | PDF Version
  • Aina Westrheim Ravna
    Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
    | PDF Version
  • Saverio Gentile
    Ion channels phosphorylopathy: 3rd International Conference on Clinical & Experimental Cardiology April 15-17, 2013 A link between genomic variations and heart arrhythmia
    | PDF Version
High Impact List of Articles
Conference Proceedings